Merck & Co., Inc. (6MK)
XETR
Real-time Data
07:00 AM
Day's Range
123.5452 wk Range
71.00Overview - 6MK - Merck & Co., Inc.
Key Statistics
Valuation
Enterprise Value
321.00B
P/E (Trailing)
‪114.86‬
PEG Ratio
‪-0.87‬
Price / Sales (TTM)
‪4.72‬
Price / Book
‪8.45‬
EV / EBITDA
‪12.51‬
Profitability
Gross Margin
‪73.53%‬
Profit Margin
‪4.76%‬
Operating Margin
‪-0.24%‬
Return on Assets
‪11.86%‬
Return on Equity
‪6.96%‬
Ownership
Shares Outstanding
2.46B
Float
2.46B
Held by Insiders
‪0.05%‬
Held by Institutions
‪83.04%‬
Price stats
Beta
‪0.22‬
50-Day Avg
‪123.73‬
200-Day Avg
‪106.52‬
Dividends
Payout Ratio
‪268.80%‬
Frequency
Quarterly
Market Cap - 6MK - Merck & Co., Inc.
Peers - 6MK - Merck & Co., Inc.
Peer Comparison
Compared with companies in Drug Manufacturers - General listed on XETR.
Profile Summary - 6MK - Merck & Co., Inc.
About
Merck & Co., Inc. is a global biopharmaceutical company focused on discovering, developing, manufacturing, and commercializing medicines, vaccines, biologic therapies, and animal health products. The company’s pharmaceutical business serves areas such as oncology, immunology, infectious diseases, cardiometabolic…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
